End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.450 CNY | +1.30% |
|
+2.25% | +6.45% |
Jun. 06 | Jointown Pharmaceutical Gets Drug Registration for Betamethasone Sodium Phosphate Injection | MT |
May. 19 | Jointown to Invest 23 Million Yuan Into Pharma-Focused Investment Fund | MT |
Company Valuation: Jointown Pharmaceutical Group Co., Ltd
Data adjusted to current consolidation scope
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 33,241 | 26,919 | 24,052 | 26,691 | 25,148 | 27,176 | - | - |
Change | - | -19.02% | -10.65% | 10.97% | -5.78% | 8.07% | - | - |
Enterprise Value (EV) 1 | 36,125 | 29,021 | 21,882 | 24,319 | 20,414 | 21,639 | 24,887 | 20,581 |
Change | - | -19.67% | -24.6% | 11.14% | -16.06% | 6% | 15.01% | -17.3% |
P/E ratio | 11.7x | 11.6x | 12.2x | 12.7x | 10.2x | 10x | 9.69x | 9.18x |
PBR | 1.75x | 1.31x | 1.09x | 1.14x | 0.95x | 0.94x | 0.9x | 0.83x |
PEG | - | -0.6x | -0.8x | 1.76x | 0.6x | 1.11x | 3.06x | 1.66x |
Capitalization / Revenue | 0.3x | 0.22x | 0.17x | 0.18x | 0.17x | 0.17x | 0.15x | 0.15x |
EV / Revenue | 0.33x | 0.24x | 0.16x | 0.16x | 0.13x | 0.13x | 0.14x | 0.11x |
EV / EBITDA | 7.36x | 6.93x | 6.21x | 6.5x | 4.61x | 4.71x | 4.87x | 3.75x |
EV / EBIT | 8.3x | 8.08x | 7.67x | 8.05x | 5.62x | 5.52x | 6x | 4.5x |
EV / FCF | - | - | - | - | - | - | - | - |
FCF Yield | - | - | - | - | - | - | - | - |
Dividend per Share 2 | 0.1858 | 0.1115 | 0.1858 | 0.1938 | 0.2 | 0.2253 | 0.221 | 0.2179 |
Rate of return | 2.75% | 2.04% | 3.83% | 3.57% | 3.91% | 4.13% | 4.05% | 4% |
EPS 2 | 0.576 | 0.472 | 0.3976 | 0.4264 | 0.5 | 0.5451 | 0.5623 | 0.5934 |
Distribution rate | 32.3% | 23.6% | 46.7% | 45.5% | 40% | 41.3% | 39.3% | 36.7% |
Net sales 1 | 110,860 | 122,407 | 140,424 | 150,140 | 151,810 | 161,909 | 175,712 | 180,399 |
EBITDA 1 | 4,909 | 4,187 | 3,526 | 3,741 | 4,427 | 4,591 | 5,114 | 5,495 |
EBIT 1 | 4,352 | 3,593 | 2,853 | 3,023 | 3,635 | 3,917 | 4,147 | 4,573 |
Net income 1 | 3,075 | 2,448 | 2,085 | 2,174 | 2,507 | 2,753 | 2,842 | 2,989 |
Net Debt 1 | 2,884 | 2,102 | -2,170 | -2,372 | -4,734 | -5,537 | -2,289 | -6,595 |
Reference price 2 | 6.749 | 5.470 | 4.846 | 5.434 | 5.120 | 5.450 | 5.450 | 5.450 |
Nbr of stocks (in thousands) | 4,925,621 | 4,921,006 | 4,963,416 | 4,911,693 | 4,911,693 | 4,986,434 | - | - |
Announcement Date | 4/26/21 | 4/25/22 | 4/24/23 | 4/26/24 | 4/28/25 | - | - | - |
1CNY in Million2CNY
Estimates
P/E ratio, Detailed evolution
P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
---|---|---|---|---|---|---|
9.87x | 0.13x | 4.64x | 4.19% | 3.73B | ||
20.77x | 0.22x | 13.73x | 0.42% | 89.8B | ||
21.93x | 0.18x | 12.42x | 1.34% | 36.64B | ||
51.34x | 3.98x | 32.86x | 1.25% | 23.7B | ||
19.05x | 1.58x | 12.23x | 1.42% | 10.56B | ||
13.83x | 0.26x | 6.76x | 2.28% | 8.59B | ||
7.12x | 0.04x | 1.09x | 4.27% | 7.6B | ||
10.88x | 1.97x | 6.85x | 2.76% | 5.83B | ||
23.93x | 1.18x | 15.39x | 2.75% | 5.21B | ||
25.56x | 0.66x | 13.58x | 3.12% | 4.54B | ||
Average | 20.43x | 1.02x | 11.96x | 2.38% | 19.62B | |
Weighted average by Cap. | 23.45x | 0.82x | 14.58x | 1.24% |
Year-on-year evolution of the PER
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- 600998 Stock
- Valuation Jointown Pharmaceutical Group Co., Ltd
Select your edition
All financial news and data tailored to specific country editions